Although there are controversies inthe analyzed studies, considering the possible benefits regarding breast cancerprevention and reduction in cardiovascular events, this systematic review suggeststhat therapy with selective estrogen receptor modulators and aspirin should bebetter investigated, and emphasizes the need for randomized trials. Here, ESR1 is linked to medical procedure.